AGENUS INC Logo

AGENUS INC

A clinical-stage biotechnology company specializing in immuno-oncology therapies.

AGEN | US

Overview

Corporate Details

ISIN(s):
US00847G8042
LEI:
Country:
United States of America
Address:
3 FORBES ROAD, 2421 LEXINGTON

Description

Agenus Inc. is a clinical-stage biotechnology company specializing in immuno-oncology (I-O). The company discovers, develops, and manufactures therapies designed to activate the body's immune system to combat cancer and infectious diseases. Its portfolio includes a broad range of immunological agents such as antibody therapeutics, adoptive cell therapies, and vaccine adjuvants. A key program is botensilimab, a next-generation CTLA-4 antibody engineered for enhanced efficacy and improved tolerability. Agenus aims to expand the patient population benefiting from I-O, including those with tumors unresponsive to current treatments, by leveraging innovative combination approaches and strategic partnerships.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-05-12 18:50
10-Q
English ZIP 1.6 MB
2025-05-12 09:32
8-K
English ZIP 98.1 KB
2025-05-06 19:21
4
English ZIP 7.0 KB
2025-05-05 18:15
DEFR14A
English ZIP 8.2 KB
2025-05-05 18:05
4
English ZIP 7.0 KB
2025-05-05 18:05
4
English ZIP 7.7 KB
2025-04-30 18:48
ARS
English ZIP 3.1 MB
2025-04-30 18:05
DEF 14A
English ZIP 6.8 MB
2025-04-22 18:05
4
English ZIP 7.7 KB
2025-04-18 18:30
PRE 14A
English ZIP 5.2 MB
2025-04-10 18:50
4
English ZIP 7.0 KB
2025-04-08 18:05
4
English ZIP 7.7 KB
2025-04-03 18:05
4
English ZIP 6.8 KB
2025-04-02 18:05
4
English ZIP 7.3 KB
2025-03-27 17:05
4
English ZIP 7.0 KB

Automate Your Workflow. Get a real-time feed of all AGENUS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AGENUS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AGENUS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.